| Primary |
| Factor Viii Deficiency |
28.4% |
| Pain |
16.8% |
| Hiv Infection |
14.4% |
| Medical Diet |
12.4% |
| Arthritis |
9.2% |
| Sleep Disorder |
4.4% |
| Haemophilia |
2.4% |
| Viral Infection |
2.4% |
| Prophylaxis |
2.0% |
| Drug Effect Decreased |
1.6% |
| Haemarthrosis |
1.6% |
| Osteoporosis |
1.2% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.2% |
| Asthma |
0.4% |
| Factor Viii Inhibition |
0.4% |
| Gastritis Prophylaxis |
0.4% |
| Haemophilia Nos |
0.4% |
| Hemophilia A |
0.4% |
|
| Factor Viii Inhibition |
61.5% |
| Drug Ineffective |
10.3% |
| Drug Effect Decreased |
6.4% |
| No Adverse Event |
6.4% |
| Gastrointestinal Infection |
2.6% |
| Haemarthrosis |
2.6% |
| Lymphadenitis |
2.6% |
| False Positive Investigation Result |
1.3% |
| Gingival Bleeding |
1.3% |
| Haematoma |
1.3% |
| Respiratory Disorder |
1.3% |
| Soft Tissue Disorder |
1.3% |
| Tongue Haemorrhage |
1.3% |
|
| Secondary |
| Factor Viii Deficiency |
21.5% |
| Pain |
18.4% |
| Hiv Infection |
16.3% |
| Medical Diet |
12.5% |
| Arthritis |
11.1% |
| Sleep Disorder |
4.5% |
| Drug Effect Decreased |
3.8% |
| Haemarthrosis |
3.8% |
| Viral Infection |
2.8% |
| Prophylaxis |
2.6% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.4% |
| Osteoporosis |
0.7% |
| Haemophilia Nos |
0.5% |
|
| Factor Viii Inhibition |
59.2% |
| Drug Ineffective |
16.3% |
| Drug Effect Decreased |
14.3% |
| No Adverse Event |
7.1% |
| False Positive Investigation Result |
2.0% |
| Gingival Bleeding |
1.0% |
|
| Concomitant |
| Factor Viii Deficiency |
100.0% |
|
| Wrong Drug Administered |
100.0% |
|
